Stereochemistry

In short

Stereochemistry studies how atoms are arranged in three dimensions in a molecule and how that arrangement controls physical properties, reactivity and biological action. Two compounds with the same bonds and connectivity can rotate plane-polarised light oppositely, smell different, or be a medicine versus a poison — so the subject governs drug design, agrochemicals, flavours and polymer manufacture. It carries heavy weight in B.Sc and M.Sc organic papers, in GATE Chemistry (CY), CSIR-UGC NET, IIT-JAM and GPAT, where R/S assignment, meso detection and conformational energy questions are almost guaranteed. Indian employers — Dr. Reddy's, Sun Pharma, Cipla, Divi's Laboratories, Aurobindo, Syngene, Piramal Pharma Solutions, Jubilant, UPL — test it directly in technical rounds because chiral purity is a regulated specification under the Drugs and Cosmetics Act, 1940 and its Rules and the Indian Pharmacopoeia.

Explained

Isomer classification and the language of stereochemistry

• Stereoisomers have the same molecular formula and the same connectivity, differing only in spatial arrangement; constitutional (structural) isomers differ in connectivity and belong to the isomerism note.
• Configurational isomers cannot interconvert without breaking a bond (enantiomers, diastereomers, cis/trans). Conformational isomers interconvert by rotation about single bonds at room temperature.
• Enantiomers: non-superimposable mirror images; identical scalar properties (m.p., b.p., solubility, NMR in an achiral medium) but opposite optical rotation and opposite behaviour toward other chiral molecules.
• Diastereomers: stereoisomers that are not mirror images; different m.p., b.p., solubility, NMR, chromatographic retention — hence separable by ordinary crystallisation or chromatography.
• Chirality: a molecule is chiral if it is not superimposable on its mirror image; the operational test is the absence of any improper symmetry element — no plane of symmetry (σ), no centre of inversion (i), no Sn axis.
• Stereocentre (stereogenic centre): an atom at which swapping two attached groups gives a different stereoisomer. A carbon with four different groups is a chirality centre (asymmetric carbon).
• Chirality without a stereocentre: allenes with different substituents at each end (axial chirality), biphenyls with bulky ortho groups that cannot rotate (atropisomers, e.g. BINAP), helicenes, and trans-cyclooctene (planar chirality).
• Pseudoasymmetric centre: written lower case r/s, where two ligands differ only as R and S mirror ligands.

Nomenclature of configuration: CIP, D/L, erythro/threo, E/Z

1. CIP (Cahn–Ingold–Prelog) sequence rules — rank the four ligands a > b > c > d: (i) higher atomic number first; (ii) for ties, explore outward sphere by sphere comparing the duplicated sets at the first point of difference; (iii) duplicate atoms for double/triple bonds (C=O counts as C bonded to (O, O-duplicate)); (iv) higher mass number first (isotopes); (v) like-precedes-unlike for R/S ligands (R > S), then Z > E.
2. Place the lowest priority group (d) away from the viewer; a > b > c clockwise = R (rectus), anticlockwise = S (sinister).
3. In a Fischer projection horizontal bonds point toward the viewer and vertical bonds away. With d (usually H) on a vertical bond, read a→b→c directly: clockwise = R. With d horizontal, read the rotation and reverse it. An even number of pairwise swaps keeps configuration; an odd number inverts it. Rotating a Fischer projection by 180° in the plane is allowed; 90° is not.
4. D/L system (Fischer–Rosanoff) is still used for sugars and amino acids and is relative, not absolute in the CIP sense: in the standard Fischer projection, the reference OH (highest-numbered chiral carbon in sugars) on the right = D, on the left = L. Natural amino acids are L; natural glucose is D. D/L does not determine the sign of rotation — D-(+)-glucose and D-(−)-fructose are both D.
5. erythro/threo (and syn/anti for the aldol literature): erythro has like groups on the same side of a Fischer projection, threo on opposite sides.
6. E/Z for alkenes and oximes: compare CIP priority on each doubly bonded carbon; higher priorities on the same side = Z (zusammen), opposite = E (entgegen). cis/trans is unambiguous only with one substituent of each kind per carbon, so E/Z is preferred by IUPAC. Geometrical isomerism also needs restricted rotation plus two different groups on each sp² carbon; it also appears in rings (cis/trans-1,2-dimethylcyclohexane) and in C=N and N=N systems.
7. (+)/(−) or d/l refer to the measured sign of optical rotation and have no fixed link to R/S. (±) denotes a racemate.

Optical activity, molecules with two or more stereocentres

• A chiral substance rotates the plane of polarised light; measured in a polarimeter at 589 nm (sodium D line) in a tube of standard path length, usually 1 dm (10 cm).
• Specific rotation [α] normalises rotation to concentration and path length; molar rotation = [α] × M/100. Both are temperature- and solvent-dependent, so conditions are always quoted.
• Maximum number of stereoisomers = 2ⁿ for n stereocentres, reduced when internal symmetry creates meso forms (achiral, optically inactive by internal compensation, with a σ plane or centre in some conformation). Tartaric acid: n = 2 but only 3 stereoisomers — (+), (−) and meso.
• Racemic mixture: 1:1 enantiomers, zero net rotation (external compensation). It is a distinct solid phase — a racemic compound (true racemate) usually has a different m.p. from the pure enantiomer, while a conglomerate melts lower than the pure enantiomer (a 50:50 eutectic).
• Optical purity / enantiomeric excess (ee) = |%R − %S| = observed rotation / rotation of pure enantiomer × 100, assuming linearity (valid in dilute, non-aggregating systems).
• Diastereomeric excess (de) describes the ratio of diastereomers from a reaction.
• Resolution — separating a racemate: (a) classical diastereomeric salt crystallisation, e.g. a racemic acid with (−)-brucine, quinine or cinchonidine, or a racemic amine with (+)-tartaric or dibenzoyl-tartaric acid; (b) kinetic resolution with an enzyme (lipase, esterase) that reacts with one enantiomer faster; (c) chiral chromatography — HPLC on amylose/cellulose-derived columns, or GC on cyclodextrin phases; (d) mechanical separation of conglomerate crystals (Pasteur's sodium ammonium tartrate, 1848).
• Racemisation: loss of optical activity by formation of a planar or symmetric intermediate — enolisation at an α-stereocentre, SN1 carbocations, radicals. Epimerisation inverts only one of several stereocentres.
• Walden inversion: SN2 proceeds with backside attack and inversion of configuration at carbon; SN1 through a planar carbocation gives racemisation with some net inversion from ion-pairing. Retention is seen in neighbouring-group participation (double inversion) and in SNi (thionyl chloride on alcohols).
• Prochirality: CH₂ hydrogens in a molecule like ethanol are pro-R/pro-S; replacing one gives R, the other S. Faces of a carbonyl are Re/Si. Enzymes distinguish them — the basis of stereospecific biochemistry.
• Topicity terms: homotopic (identical by rotation), enantiotopic (distinguishable only in a chiral environment), diastereotopic (distinct NMR signals, different reactivity).

Conformational analysis

• Ethane: rotation about C–C gives staggered (minimum) and eclipsed (maximum) conformers; the barrier is about 12 kJ/mol, mostly hyperconjugative/torsional strain, not steric.
• Butane (about C2–C3): anti (dihedral 180°, lowest) < gauche (60°, about 3.8 kJ/mol higher) << eclipsed-methyl/H (about 16 kJ/mol) < fully eclipsed syn (about 19–20 kJ/mol). Drawn with Newman or sawhorse projections.
• Strain types: torsional (eclipsing), steric/van der Waals, angle (Baeyer) strain, and A-strain (allylic/1,3-diaxial).
• Cyclohexane is not planar; the chair is strain-free (all bonds staggered, angles near 111°). The twist-boat lies about 23 kJ/mol above the chair, the boat about 29 kJ/mol (flagpole interactions plus eclipsing), and the half-chair is the transition state.
• Ring flipping (chair ↔ chair through half-chair and twist-boat) interconverts axial and equatorial positions at about 45 kJ/mol; it is fast at room temperature, which is why cis-1,2-dimethylcyclohexane does not resolve into enantiomers at ordinary temperature.
• Conformational preference: a substituent prefers equatorial to avoid two 1,3-diaxial interactions. A-values (−ΔG°, kJ/mol, approximate): CH₃ 7.3, CH₃CH₂ 7.5, i-Pr 9.2, t-Bu about 20 (conformationally locked, "anchoring" group), OH 2.1–4, Ph 12.5.
• cis/trans disubstituted cyclohexanes: 1,2- and 1,4-: trans-1,2 is (a,a)/(e,e) and cis-1,2 is (a,e); for 1,4, trans is (e,e) and is the more stable; for 1,3 the cis isomer is (e,e) and more stable. Useful rule: a 1,2- or 1,4-relationship that is trans can be diequatorial; a 1,3-trans cannot.
• Decalin: trans-decalin is rigid and more stable than cis-decalin by about 11 kJ/mol; cis-decalin can ring-flip.
• Fused/bridged systems: Bredt's rule forbids a double bond at the bridgehead of small bicyclics.
• Anomeric effect: in pyranoses and 2-substituted tetrahydropyrans, an electronegative group at C-1 prefers axial, against the steric expectation, because of nO→σ*C–X donation; central to carbohydrate chemistry.
• Conformation controls reaction rate and outcome: E2 requires anti-periplanar H and leaving group (so only the axial-H, axial-LG chair reacts in cyclohexanes); chromic acid oxidation and ester hydrolysis rates differ between axial and equatorial isomers.

Stereochemistry of reactions

• Stereospecific reaction: the stereochemistry of the product is determined by that of the substrate (SN2, E2, bromination of alkenes). Stereoselective: one stereoisomer predominates from a substrate that could give several (NaBH₄ reduction of a ketone, aldol reactions).
• syn addition: catalytic hydrogenation (H₂/Pd, Pt, Ni), OsO₄ or cold alkaline KMnO₄ dihydroxylation, hydroboration–oxidation (syn and anti-Markovnikov).
• anti addition: Br₂ or Cl₂ via the bridged halonium ion, epoxidation then acid-catalysed ring opening (anti diol).
• Syn/anti outcomes on alkene geometry: cis-2-butene with Br₂ gives the (±) pair; trans-2-butene gives the meso dibromide — a classic exam question.
• Eliminations: E2 is anti-periplanar and often anti-stereospecific; Zaitsev gives the more substituted alkene, Hofmann the less substituted with bulky base or quaternary ammonium hydroxide; E1cb and Cope/Hofmann (syn-periplanar) eliminations differ.
• Rearrangements and retention: Beckmann, Baeyer–Villiger and Curtius migrate with retention of configuration at the migrating carbon.
• Asymmetric synthesis: chiral pool (from natural L-amino acids, sugars, terpenes), chiral auxiliaries (Evans oxazolidinones), chiral catalysts (Sharpless epoxidation, Noyori BINAP hydrogenation, CBS reduction, organocatalysis with proline). Cram's rule / Felkin–Anh and the Zimmerman–Traxler chair model predict diastereofacial selectivity.
• Curtin–Hammett principle: when conformers interconvert faster than they react, the product ratio depends on the relative transition-state energies, not on conformer populations.

Regulatory and analytical practice in India

• Chirality is a critical quality attribute. Indian Pharmacopoeia monographs and USP/Ph.Eur. equivalents specify optical rotation limits and, for single-enantiomer drugs, an enantiomeric purity limit (commonly not more than 0.5–1.0% of the undesired enantiomer; the exact figure is monograph-specific).
• Manufacture and testing fall under the Drugs and Cosmetics Act, 1940 and Rules (Schedule M GMP, revised and effective for most manufacturers from 2025) and the quality-control requirements of CDSCO; new-drug and chiral-switch applications are governed by the New Drugs and Clinical Trials Rules, 2019.
• Standard methods: polarimetry (specific rotation), chiral HPLC/SFC with UV or CD detection, chiral GC, NMR with chiral shift reagents or Mosher's acid derivatisation, optical rotatory dispersion and circular dichroism, and single-crystal X-ray for absolute configuration (originally by Bijvoet's anomalous dispersion on sodium rubidium tartrate, 1951).
• Why it matters clinically: thalidomide (one enantiomer sedative, the other teratogenic — though it racemises in vivo), S-(−)-propranolol far more active as a beta blocker, esomeprazole and levocetirizine marketed as single enantiomers, levofloxacin versus ofloxacin, S-(+)-ibuprofen as the active form. Several of these "chiral switch" products are made in Indian plants for export.

Key points

• Chirality — non-superimposability on the mirror image; equivalent to having no σ plane, no centre of symmetry and no Sn axis.
• Enantiomers — mirror images; same scalar properties, equal and opposite rotation, different biological action.
• Diastereomers — not mirror images; different physical properties, hence separable by ordinary methods.
• Meso compound — has stereocentres but an internal mirror plane, so it is achiral and optically inactive.
• Racemate (±) — equimolar enantiomers, net rotation zero; needs resolution, not distillation.
• 2ⁿ rule — maximum stereoisomers for n stereocentres; fewer when meso forms exist.
• CIP priority — atomic number first, explore outward sphere by sphere, duplicate atoms of multiple bonds, isotopes by mass, then R > S and Z > E.
• Fischer projection — horizontal toward viewer, vertical away; 180° rotation allowed, 90° not; one swap inverts configuration.
• D/L is relative, (+)/(−) is measured, R/S is absolute — no automatic correlation between them.
• Specific rotation [α] — rotation per unit concentration and path length; quoted with temperature, wavelength and solvent.
• Enantiomeric excess — |%R − %S|; 90% ee means 95:5 enantiomer ratio.
• Conformer energies — ethane barrier about 12 kJ/mol; butane anti < gauche by about 3.8 kJ/mol.
• Cyclohexane chair — strain-free; equatorial preferred to avoid 1,3-diaxial strain; flip barrier about 45 kJ/mol.
• A-value — equatorial preference in kJ/mol: CH₃ 7.3, i-Pr 9.2, t-Bu about 20 (locks the ring).
• trans-1,2, trans-1,4 and cis-1,3 disubstituted cyclohexanes can be diequatorial and are the more stable isomers.
• Anti versus syn addition — halogens add anti through a halonium ion; hydrogenation, OsO₄ and hydroboration add syn.
• Stereospecific versus stereoselective — substrate-determined versus preference among possible products.
• Walden inversion — SN2 inverts configuration at the attacked carbon; SN1 largely racemises.
• Resolution routes — diastereomeric salts, enzymatic kinetic resolution, chiral chromatography, conglomerate picking.

Formulas and examples

Example 1 — specific rotation. A solution of 1.20 g of a sugar in 20.0 mL of water gives α = +3.18° in a 1.0 dm tube at 25 °C.

• c = 1.20/20.0 = 0.0600 g/mL.
• [α]²⁵_D = 3.18 / (1.0 × 0.0600) = +53.0° (c 6.0, water).
• If the same solution were read in a 2 dm tube, α would be +6.36°; [α] is unchanged, since it is normalised.

Example 2 — enantiomeric excess and composition. Pure (S)-naproxen has [α]_D = +66°. A batch reads [α]_D = +59.4° under identical conditions.

• ee = (59.4/66) × 100 = 90.0%.
• %S = (100 + 90)/2 = 95.0%; %R = 5.0% → enantiomer ratio 95:5, i.e. 19:1.
• Mass of unwanted R in a 50 kg batch = 0.05 × 50 = 2.5 kg — far above a typical 0.5–1.0% pharmacopoeial limit, so the batch needs further resolution or recrystallisation.

Example 3 — conformer population of methylcyclohexane at 298 K. A-value for CH₃ = 7.3 kJ/mol (equatorial favoured).

• K = exp(7300 / (8.314 × 298)) = exp(2.947) = 19.0.
• Equatorial fraction = 19.0/20.0 = 95.0%; axial = 5.0%.
• Repeat at 400 K: K = exp(7300/(8.314 × 400)) = exp(2.195) = 8.98 → equatorial 90.0% — higher temperature flattens the preference, as entropy favours the minor conformer's population.

Example 4 — counting stereoisomers. (a) 2,3-dibromobutane: n = 2, so 2² = 4 predicted, but the two ends are identical, so one pair collapses into a meso form → 3 stereoisomers: (2R,3R), (2S,3S) and meso (2R,3S). (b) 2,3,4-trihydroxybutanal (a tetrose-type chain): n = 2 with different ends → full 4 stereoisomers (two enantiomeric pairs, D/L-erythrose and D/L-threose). (c) 2,3,4-tribromopentane: n = 3 but C-3 is pseudoasymmetric with identical ends → fewer than 8; careful enumeration gives 4 distinct stereoisomers.

Example 5 — stereospecific bromination. Add Br₂ in CCl₄ to (Z)-2-butene.

• Br⁺ forms a cyclic bromonium ion; Br⁻ attacks the opposite face (anti).
• Anti addition to the cis alkene gives 2,3-dibromobutane as the (R,R) + (S,S) racemate, optically inactive as a mixture but resolvable.
• The same reaction on (E)-2-butene gives the (2R,3S) meso product, optically inactive and not resolvable. Identical formula, different stereochemistry — proof the mechanism is anti and stereospecific.

Where it is used

• API and intermediate manufacture: single-enantiomer drugs (esomeprazole, levofloxacin, clopidogrel, sitagliptin, levetiracetam) at Dr. Reddy's, Sun Pharma, Divi's, Aurobindo, MSN and Hetero — chiral purity released on chiral HPLC before dispatch.
• CRO/CDMO research roles: Syngene, Piramal Pharma Solutions, Jubilant Biosys, Aragen and Sai Life Sciences run asymmetric synthesis, route scouting and resolution development; interviews lead with R/S, de/ee and chiral analysis.
• Analytical and QC jobs: polarimetry, chiral HPLC/GC method development and validation under Schedule M GMP and ICH Q2/Q3 expectations; QC chemist and method-development analyst roles.
• Agrochemicals and flavours: UPL, Rallis, PI Industries make enantio-enriched pyrethroids and metolachlor-type herbicides where one enantiomer carries nearly all the activity; carvone, menthol and limonene differ in smell by enantiomer.
• Polymers and catalysis: isotactic, syndiotactic and atactic polypropylene (tacticity is stereochemistry of the chain) from Ziegler–Natta catalysts at Reliance, IOCL and HMEL plants; stereoregularity sets crystallinity and melting point.
• Academia and competitive exams: GATE CY, CSIR-UGC NET, IIT-JAM, GPAT and teaching/NET-JRF posts; biochemistry and enzymology research rests on prochirality and stereospecific enzyme action.

Interview questions

• Q: What is the difference between configuration and conformation? A: Configuration is a spatial arrangement that cannot be changed without breaking bonds; conformation differs only by rotation about single bonds and interconverts freely at room temperature.
• Q: How do you decide whether a molecule is chiral without building a model? A: Look for improper symmetry elements — if the molecule has a mirror plane, a centre of inversion or any Sn axis in any accessible conformation, it is achiral; otherwise it is chiral.
• Q: Tartaric acid has two stereocentres, so why are there only three stereoisomers? A: The two ends are identical, so the (R,S) and (S,R) forms are the same achiral meso compound, leaving (+), (−) and meso.
• Q: Does a compound need a chiral carbon to be optically active? A: No — allenes, substituted biphenyls (atropisomers), helicenes and spiranes are chiral through axial, planar or helical chirality with no asymmetric carbon.
• Q: Is R always (+) and S always (−)? A: No. R/S is an absolute descriptor from CIP rules; the sign of rotation is an experimental property that depends on solvent, wavelength and temperature, with no fixed correlation.
• Q: Why is the equatorial conformer of methylcyclohexane favoured? A: An axial methyl suffers two 1,3-diaxial (gauche-butane type) interactions worth about 7.3 kJ/mol in total, so about 95% sits equatorial at 298 K.
• Q: How would you separate a racemic carboxylic acid industrially? A: Form diastereomeric salts with a resolving base such as quinine, brucine or (R)-phenylethylamine, crystallise the less soluble salt fractionally, then acidify to release the enriched enantiomer; or use enzymatic kinetic resolution or a chiral preparative column.
• Q: What product does bromine give with trans-2-butene, and why? A: anti Addition through a bromonium ion gives meso-2,3-dibromobutane — optically inactive and not resolvable, unlike the (R,R)/(S,S) racemate obtained from the cis alkene.
• Q: Explain stereospecific versus stereoselective with one example each. A: SN2 is stereospecific — the product configuration is dictated by the substrate and inverts every time; NaBH₄ reduction of a hindered ketone is stereoselective — it merely favours attack from the less hindered face.
• Q: Why does an SN1 reaction give racemisation but often with slight net inversion? A: The planar carbocation can be attacked from either face, but the departing leaving group shields one face in the ion pair, so the inverted product is marginally in excess.
• Q: What is the anomeric effect and why is it surprising? A: An electronegative substituent at C-1 of a pyranose prefers the axial position, against sterics, because a ring-oxygen lone pair donates into the σ* orbital of the C–X bond.
• Q: Why must a pharmaceutical company control the "wrong" enantiomer? A: It can be inactive, less active or toxic and is treated as an impurity with a monograph limit; IP/USP specifications and CDSCO requirements under the Drugs and Cosmetics Rules make enantiomeric purity a release test.

Common mistakes

• Rotating a Fischer projection by 90° (which inverts the configuration) or forgetting to reverse the reading when the lowest-priority group lies on a horizontal bond.
• Assuming R means (+) and D means (+), or mapping D/L onto R/S — three independent systems.
• Calling any compound with two stereocentres chiral and missing the meso form, or declaring a meso compound "a racemic mixture".
• Ranking CIP priorities by the number of attached atoms or by group size instead of by atomic number at the first point of difference.
• Drawing cyclohexane as a flat hexagon and then arguing about axial/equatorial, or flipping a ring and forgetting that cis stays cis — ring flip swaps axial/equatorial but never changes configuration.
• Treating a racemate as separable by distillation or ordinary crystallisation; only diastereomers (or chiral environments) can be separated that way.
• Reporting specific rotation without concentration, solvent, temperature and wavelength, or substituting concentration in g/L instead of g/mL and path length in cm instead of dm.

Related topics

Organic nomenclature and isomerism · Organic reaction mechanisms · Carbohydrates and amino acids · Chiral chromatography and spectroscopic methods of analysis · Coordination chemistry: isomerism in complexes · Polymer stereochemistry and tacticity